Search Browse Earnings

Processa Pharmaceuticals, Inc.

Nasdaq:PCSA

Pharmaceutical Preparations·VERO BEACH, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2022

Adj. EBITDA

-$11.5M

FY 2024

Net Income

-$11.1M

FY 2024

EPS (Diluted)

-$8.48

FY 2024

Stock Price

$2.92

+4.3%

2026-03-10

52W Range

$1.76 – $19.63

P/E Ratio

-0.3x

Market Cap

$165.4M

Cash

$4.7M

FY 2024

Total Debt

$2.4M

FY 2018

Net Cash

$2.3M

FY 2018

Enterprise Value

$163.1M

Debt / EBITDA

0.2x

FY 2022

EV / EBITDA

-14.2x

Employees

—